nor-BNI Antagonism of Kappa Opioid Agonist-Induced Reinstatement of Ethanol-Seeking Behavior

nor-BNI Antagonism of Kappa Opioid Agonist-Induced Reinstatement of Ethanol-Seeking Behavior

Recent work suggests that the dynorphin (DYN)/kappa opioid receptor (KOR) system may be a key mediator in the behavioral effects of alcohol. The objective of the present study was to examine the ability of the KOR antagonist norbinaltorphimine (nor-BNI) to attenuate relapse to ethanol seeking due to...

Full description

Bibliographic Details
Main Authors:	Erin Harshberger, Emily A. Gilson, Kelli Gillett, Jasmine H. Stone, Laila El Amrani, Glenn R. Valdez
Format:	Article
Language:	English
Published:	Hindawi Limited 2016-01-01
Series:	Journal of Addiction
Online Access:	http://dx.doi.org/10.1155/2016/1084235

Similar Items

Effects of a post-shock injection of the kappa opioid receptor antagonist norbinaltorphimine (norBNI) on fear and anxiety in rats.
by: Benjamin Rogala, et al.
Published: (2012-01-01)

Therapeutic Potential of Kappa Opioid Agonists
by: Tyler C. Beck, et al.
Published: (2019-06-01)

Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters.
by: Thomas A Munro, et al.
Published: (2013-01-01)

The effects of Kappa Opioid Agonists on Ocular Hydrodynamics
by: Moore, Tisha T
Published: (2000)

Studies on the neuroprotective action of the kappa-opioid agonist enadoline
by: Hayward, Neil James
Published: (1993)

Renal, vascular and endocrine effects of Kappa opioid agonists
by: Blackburn, Thomas P.
Published: (1989)

Studies on the clinical pharmacology of kappa opioid receptor agonists
by: Rimoy, Gerald Herman
Published: (1991)

Exposure to chronic mild stress prevents kappa opioid-mediated reinstatement of cocaine and nicotine place preference
by: Ream eAl-Hasani, et al.
Published: (2013-08-01)

The cardiovascular actions of mu and kappa opioid agonists in vivo and in vitro
by: Omoniyi, Abimbola T.
Published: (1998)

Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors
by: Rossi Heather L, et al.
Published: (2007-09-01)

The cardiovascular and antiarrhythmic actions of a series of kappa opioid agonists and related compounds
by: Pugsley, Michael Kenneth
Published: (2009)

The cardiovascular and antiarrhythmic actions of a series of kappa opioid agonists and related compounds
by: Pugsley, Michael Kenneth
Published: (2009)

Itching-like behavior: A common effect of the kappa opioid receptor antagonist 5′-guanidinonaltrindole and the biased kappa opioid receptor agonist 6′-guanidinonaltrindole in mice
by: Alan Cowan, et al.
Published: (2021-09-01)

Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation
by: Hurramhon Shokirova, et al.
Published: (2021-04-01)

The effects of kappa opioid and dopamine agonists on unconditioned behaviors and fos immunoreactivity in preweanling and adult rats
by: Duke, Marcus Alan
Published: (1996)

Diuretic Activity of a Novel Peripherally-Restricted Orally-Active Kappa Opioid Receptor Agonist
by: Tyler C. Beck, et al.
Published: (2019-08-01)

The Role of Kappa Opioid Agonist U50,488H in Consummatory Successive Negative Contrast
by: Wood, Michael David
Published: (2006)

Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic
by: Saadet Inan, et al.
Published: (2021-09-01)

Analgesic Activity of the Kappa Opioid Receptor Agonist - RU-1205 in Rats / Spasov AA ... [et al.]
by: AA, Spasov, et al.
Published: (2018)

Kappa opioid regulation of depressive-like behavior during acute withdrawal and protracted abstinence from ethanol.
by: Sorscha K Jarman, et al.
Published: (2018-01-01)

Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation
by: Kook Jin Chun, et al.
Published: (2010-02-01)

The Differential Effects of a Selective Kappa-Opioid Receptor Agonist, U50488, in Guinea Pig Heart Tissues
by: Chi-Feng Hung, et al.
Published: (2015-01-01)

Distribution, excretion and metabolic pathways of a single parenteral administration of kappa-opioid receptor agonist RU-1205
by: Alexander A. Spasov, et al.
Published: (2021-06-01)

Implementasi CSR melalui Program "Kampoeng BNI" oleh PT. BNI (Persero) TBK
by: Mayang Riyantie
Published: (2013-12-01)

Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking.
by: Islam Gamaleddin, et al.
Published: (2012-01-01)

Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking
Published: ()

Agonist bias and agonist‐dependent antagonism at corticotrophin releasing factor receptors
by: Zoe Tasma, et al.
Published: (2020-06-01)

Biochemical and pharmacological studies of the Kappa opioid receptor
by: Richardson, Alan
Published: (1989)

Evaluation of Antinociceptive Effects of Chitosan-Coated Liposomes Entrapping the Selective Kappa Opioid Receptor Agonist U50,488 in Mice
by: Liliana Mititelu Tartau, et al.
Published: (2021-02-01)

Murabahah accounting in BNI Syariah Makassar
by: Firman Manne, et al.
Published: (2018-07-01)

MURABAHAH ACCOUNTING IN BNI SYARIAH MAKASSAR
by: Firman Menne
Published: (2017-08-01)

Galanin-3 Receptor Antagonism by SNAP 37889 Reduces Motivation to Self-administer Alcohol and Attenuates Cue-Induced Reinstatement of Alcohol-Seeking in iP Rats
by: Belinda L. Ash, et al.
Published: (2014-01-01)

Comparación de uniones soldadas hechas con aleaciones de níquel BNi-1 y BNi-7
by: Borut Zorc, et al.
Published: (2000-04-01)

Nanobody-enabled monitoring of kappa opioid receptor states
by: Tao Che, et al.
Published: (2020-03-01)

Cardiorenal Effects of Kappa Opioid Peptides During Ontogeny
by: Wei Qi, et al.
Published: (2011-01-01)

The kappa opioid receptor: from addiction to depression, and back
by: Laurence eLalanne, et al.
Published: (2014-12-01)

Kappa opioid actions in the rat locus coeruleus in vitro
by: McFadzean, I.
Published: (1986)

Role of Kappa-Opioid Receptors in Stress-Induced Behaviors
by: Van't Veer, Ashlee Victoria
Published: (2013)

Salvinorin A, a kappa-opioid receptor (KOP-r) agonist hallucinogen: Pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
by: Eduardo eButelman, et al.
Published: (2015-09-01)

New Neurons in the Dentate Gyrus Promote Reinstatement of Methamphetamine Seeking
by: Chitra D Mandyam, et al.
Published: (2018-06-01)